We're excited to present award-winning research on GIMOTI® at #ACG2024, Oct 25-29 in Philly!
Our poster P3339 won the Outstanding Research & Presidential Poster Awards!
Check out our session. dates and times in our press release: https://t.co/HNNzPCeTT6.
$EVOK #gastroparesis
August is GASTROPARESIS AWARENESS Month. 67% of patients rate their current health as fair or poor*. Yet, many believe they are "doing fine." Let's ask a few more questions to increase our "awareness" of how patients are really doing.
#GIImpact#GITwitter
*2019 survey by IFFGD
@EvokePharmCorp is proud to advocate loudly for patients with #gastroparesis. Wont you join Team GIMOTI in raising awareness and money to support patient programs and GI research. 🖱️ to join our team or DONATE today!
https://t.co/YHh0fMcgU5 via @CharityFtprints
@4GPACT is holding their first ever patient conference for #Gastroparesis. @EvokePharmCorp is proud to sponsor. Spread the word. Have patients register @ https://t.co/rLiTLPe2Dp
#thisisgp
What a time to be at #ACG2023! Our team and EVERSANA are on the ground, connecting with the esteemed professional community at ACG. Stop by our booth and our presentation on Wednesday if you're in attendance!
#EVOK#FightDGP#GIMOTI@AmCollegeGastro
Did you know that #migraine is comorbid with many #gastrointestinal conditions including gastroparesis?
Learn about #gastroparesis, its symptoms, relationship to migraine and more: https://t.co/Oc3m3wJUpr
Our AGMD August 2023 Gastroparesis Awareness Month Speaker | Interview Program Series will feature Melissa Adams VanHouten on Wednesday, August 30th. The focus will be on advocacy. Register Today! https://t.co/8oGFp5QY7D
#gastroparesis#gastroparesisawareness#agmdhope
Patients with diabetic gastroparesis treated with nasal metoclopramide have fewer office visits, ER visits and hospital admissions than those given an oral formulation. #gastroparesis@UCSD_GI https://t.co/ggLDUP1V6y